There’s a rich history of research suggesting that glutamate may be involved in the pathogenesis of schizophrenia, with an increasing amount of attention being brought to glutamate during the past decade or so.
Read More
Rachel Loewy, PhD, explores evidence-based psychosocial interventions for schizophrenia: CBT, multifamily group therapy, supported employment, and cognitive remediation.
Read More
Depression is a known risk factor for cardiovascular disease (CVD), but, surprisingly, it’s not known whether effectively treating depression can reduce the risk of a future cardiovascular event in depressed patients without preexisting CVD.
Read More
Psychiatric disorders account for billions of dollars of costs related to absenteeism, reduced productivity, and treatment each year. Most research in this area has focused on standard DSM diagnoses, but it may be more informative to look instead at psychiatric symptoms, such as insomnia and emotional distress, and their effect on the workplace.
Read More
People born to women between the ages of 12 and 19 or to men over the age of 45 are at the greatest risk for developing psychiatric disorders, according to the results of a Danish population-based study of close to three million people born between 1955 and 2006.
Read More
Recent research published in the Journal of the American Medical Association (JAMA) found that vitamin E slowed functional decline in Alzheimer’s disease better than memantine (Namenda) (Dysken MW et al, JAMA 2014;311(1):33-44).
Read More
Dr. Aiken is the Editor in Chief of The Carlat Psychiatry Report; director of the Mood Treatment Center in North Carolina, where he maintains a private practice combining medication and therapy along with evidence-based complementary and alternative treatments; and Assistant Professor NYU Langone Department of Psychiatry. He has worked as a research assistant at the NIMH and a sub-investigator on clinical trials, and conducts research on a shoestring budget out of his private practice. Follow him on Twitter and find him on LinkedIn.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.jpg?1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
